BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharif-zak M, Abbasi-jorjandi M, Asadikaram G, Ghoreshi Z, Rezazadeh-jabalbarzi M, afsharipur A, Rashidinejad H, Khajepour F, Jafarzadeh A, Arefinia N, Kheyrkhah A, Abolhassani M. CCR2 and DPP9 expression in the peripheral blood of COVID-19 patients: Influences of the disease severity and gender. Immunobiology 2022;227:152184. [DOI: 10.1016/j.imbio.2022.152184] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Tanaka T, Suzuki H, Asano T, Li G, Nanamiya R, Tateyama N, Isoda Y, Okada Y, Kobayashi H, Yoshikawa T, Kaneko MK, Kato Y. Epitope Mapping of an Anti-Mouse CCR2 Monoclonal Antibody (C2Mab-6) Using Enzyme-Linked Immunosorbent Assay. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 2022. [DOI: 10.1089/mab.2022.0020] [Reference Citation Analysis]
2 Nhung VP, Ton ND, Ngoc TTB, Thuong MTH, Hai NTT, Oanh KTP, Hien LTT, Thach PN, Hai NV, Ha NH. Host Genetic Risk Factors Associated with COVID-19 Susceptibility and Severity in Vietnam. Genes 2022;13:1884. [DOI: 10.3390/genes13101884] [Reference Citation Analysis]
3 Tanaka T, Suzuki H, Li G, Nanamiya R, Isoda Y, Okada Y, Kobayashi H, Yoshikawa T, Kaneko MK, Kato Y. Epitope Mapping of the Anti-Human CC Chemokine Receptor Type-2 Monoclonal Antibody (K036C2). Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 2022;41:285-289. [DOI: 10.1089/mab.2022.0018] [Reference Citation Analysis]
4 Pius-sadowska E, Niedźwiedź A, Kulig P, Baumert B, Sobuś A, Rogińska D, Łuczkowska K, Ulańczyk Z, Wnęk S, Karolak I, Paczkowska E, Kotfis K, Kawa M, Stecewicz I, Zawodny P, Machaliński B. CXCL8, CCL2, and CMV Seropositivity as New Prognostic Factors for a Severe COVID-19 Course. IJMS 2022;23:11338. [DOI: 10.3390/ijms231911338] [Reference Citation Analysis]
5 Cui C, Tian X, Wei L, Wang Y, Wang K, Fu R. New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors. Front Pharmacol 2022;13:1002871. [DOI: 10.3389/fphar.2022.1002871] [Reference Citation Analysis]
6 Pomar CA, Bonet ML, Ferre-beltrán A, Fraile-ribot PA, García-gasalla M, Riera M, Picó C, Palou A. Increased mRNA Levels of ADAM17, IFITM3, and IFNE in Peripheral Blood Cells Are Present in Patients with Obesity and May Predict Severe COVID-19 Evolution. Biomedicines 2022;10:2007. [DOI: 10.3390/biomedicines10082007] [Reference Citation Analysis]
7 Sharif-zak M, Abbasi-jorjandi M, Asadikaram G, Ghoreshi Z, Rezazadeh-jabalbarzi M, Rashidinejad H. Influence of Disease Severity and Gender on HLA-C Methylation in COVID-19 Patients. Iran J Sci Technol Trans Sci 2022. [DOI: 10.1007/s40995-022-01334-1] [Reference Citation Analysis]
8 Ghoreshi Z, Nakhaee M, Samie M, Zak MS, Arefinia N. Innate immune sensors for detecting nucleic acids during infection. LaboratoriumsMedizin 2022;46:155-164. [DOI: 10.1515/labmed-2021-0173] [Reference Citation Analysis]
9 Tanaka T, Li G, Asano T, Kaneko MK, Suzuki H, Kato Y. Epitope Mapping of the Anti-Human CCR2 Monoclonal Antibody C2Mab-9. Monoclon Antib Immunodiagn Immunother 2022. [PMID: 35666539 DOI: 10.1089/mab.2022.0012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]